Funding, News and Announcements

Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g. research, quality improvement, or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

The intent of this Request for Proposal is to support:

• Research on the therapeutic application of an oral CGRP antagonist, rimegepant, in migraine, headache, and other diseases where CGRP antagonism may be of clinical benefit
• The development of tools for clinicians and patients to improve the care of migraine patients 
• Research regarding health disparities associated with migraine.

Individual projects requesting up to $ 500,000 USD will be considered. Pfizer anticipates awarding up to 4-6 grants.

Click here for full details about this call [PDF].

Letter of Intent Deadline

Internal: February 1, 2023 at 4:30pm. Contact email is ird@dal.ca. For additional resources, click here for guidance on internal deadlines and submission processes.

Funder: February 15, 2023 at 11:59pm EST. Contact person is Jessica Romano, Jessica.Romano@pfizer.com.